• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 265

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin

Therapy or Threat? UK Expert Warns of Rising Ketamine Addiction as Phase III Alcoholism Trial Launches

The Psychedelic News Feed: January 5 – June 1, 2025

Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Moves to Ban Kraton Compound 7-OH; What Is Sinema Selling?

Mareesa Stertz & Tania Abdul – Sphinx Gate: Know Thyself at Burning Man

Tryp Therapeutics Announces Provisional Patent Filing For Improved Administration of Psychedelics

atai Life Sciences AG Announces Equity Investment in and Strategic Partnership...

Psychedelic Capitalism and Other Myths: Is the Joke On Us?

Psychotic- vs. Psychedelic-Induced Hallucinations: A Closer Look

Bright Minds Biosciences Announces Closing of $25.9 Million Unit Offering

Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal...

Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces...

Psyched Wellness Submits a Provisional Patent Application For AME-1

Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug...

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for...

1...264265266...294Page 265 of 294

EDITOR PICKS

GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin

Therapy or Threat? UK Expert Warns of Rising Ketamine Addiction as...

The Psychedelic News Feed: January 5 – June 1, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©